04:37 PM EDT, 08/26/2025 (MT Newswires) -- Cognition Therapeutics ( CGTX ) said Tuesday it was informed by Nasdaq that the company had regained compliance with the minimum bid price requirement for continued listing on the exchange.
The company's shares were up about 6% in recent after-hours activity.